Traditional Chinese Medicine Reduces Heart Attack Inflammation via MK2/TTP Pathway

Qing-Xin-Jie-Yu Granule attenuated post-heart attack inflammation by regulating the MK2/TTP pathway in both mouse models and cell cultures.

Qi, Jianghan et al.·Pharmaceutical biology·2025·lowAnimal StudyAnimal Study
RPEP-13135Animal Studylow2025RETHINKTHC RESEARCH DATABASErethinkthc.com/research

Quick Facts

Study Type
Animal Study
Evidence
low
Sample
N=Not specified (animal study)
Participants
Mice with induced myocardial infarction; H9C2 cardiomyocytes

What This Study Found

QXJYG reduced post-MI inflammation and improved cardiac function by modulating the MK2/TTP anti-inflammatory pathway.

Key Numbers

Mouse MI model (LAD ligation); improved echocardiographic function; reduced serum injury markers; modulated MK2/TTP pathway proteins in vivo and in vitro.

How They Did This

Mouse MI model (LAD ligation), in vitro hypoxic H9C2 cells, echocardiography, histology, ELISA, and pathway analysis.

Why This Research Matters

Understanding the molecular mechanisms of traditional medicines can validate their use and potentially lead to new drug targets.

The Bigger Picture

Bridging traditional Chinese medicine with modern molecular pharmacology validates ancient practices and identifies actionable drug targets.

What This Study Doesn't Tell Us

Mouse model and cell culture — human clinical trial data for this specific indication is needed. TCM formulation standardization varies.

Questions This Raises

  • ?Could MK2/TTP-targeting drugs replicate QXJYG's benefits?
  • ?Has QXJYG been tested in human MI patients?

Trust & Context

Key Stat:
MK2/TTP pathway Identified molecular mechanism for QXJYG's anti-inflammatory cardioprotective effects
Evidence Grade:
Preclinical study with clear mechanism — strong in mice but requires human validation.
Study Age:
Published in 2025, contributing mechanistic evidence for traditional Chinese medicine in cardiology.
Original Title:
Qing-Xin-Jie-Yu Granule attenuates myocardial infarction-induced inflammatory response by regulating the MK2/TTP pathway.
Published In:
Pharmaceutical biology, 63(1), 128-140 (2025)
Database ID:
RPEP-13135

Evidence Hierarchy

Meta-Analysis / Systematic Review
Randomized Controlled Trial
Cohort / Case-Control
Cross-Sectional / Observational
Case Report / Animal StudyOne case or non-human subjects
This study

Tests effects in animals (usually mice or rats), not humans.

What do these levels mean? →

Frequently Asked Questions

Can traditional Chinese medicine help after a heart attack?

This study shows QXJYG reduces inflammation and improves heart function in mice after MI, but human clinical trials are needed.

What is the MK2/TTP pathway?

A cellular signaling pathway that regulates inflammatory responses — QXJYG appears to modulate it to reduce harmful inflammation after heart injury.

Read More on RethinkPeptides

Cite This Study

RPEP-13135·https://rethinkpeptides.com/research/RPEP-13135

APA

Qi, Jianghan; Gao, Xiaoyao; Han, Ying; Yang, Meiling; Wei, Chenyi; Zhang, Ling; Chu, Jianfeng. (2025). Qing-Xin-Jie-Yu Granule attenuates myocardial infarction-induced inflammatory response by regulating the MK2/TTP pathway.. Pharmaceutical biology, 63(1), 128-140. https://doi.org/10.1080/13880209.2025.2467377

MLA

Qi, Jianghan, et al. "Qing-Xin-Jie-Yu Granule attenuates myocardial infarction-induced inflammatory response by regulating the MK2/TTP pathway.." Pharmaceutical biology, 2025. https://doi.org/10.1080/13880209.2025.2467377

RethinkPeptides

RethinkPeptides Research Database. "Qing-Xin-Jie-Yu Granule attenuates myocardial infarction-ind..." RPEP-13135. Retrieved from https://rethinkpeptides.com/research/qi-2025-qingxinjieyu-granule-attenuates-myocardial

Access the Original Study

Study data sourced from PubMed, a service of the U.S. National Library of Medicine, National Institutes of Health.

This study breakdown was produced by the RethinkPeptides research team. We analyze and report published research findings without making health recommendations. All interpretations are based solely on the published abstract and study data.